ELYSE BROUCEK: Open Payments
NPI 1770180960 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 63 payments from 15 companies in 2025. Trend: 2023 $257 · 2024 $783 · 2025 $1,319
Food & beverage: $1,319
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $274 |
| Organon LLC | 14 | $218 |
| UCB, Inc. | 13 | $189 |
| GENZYME CORPORATION | 3 | $92 |
| Botanix SB Inc | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| Janssen Biotech, Inc. | 4 | $68 |
| Lilly USA, LLC | 4 | $66 |
| Amgen Inc. | 3 | $57 |
| LEO Pharma Inc. | 2 | $52 |
Products named: DUPIXENT, VTAMA, Bimzelx, SOFDRA, TREMFYA, TALTZ, Rhapsido, OTEZLA.
Industry payments across AZ — which companies pay providers there.
